CTNM Archived Articles
Contineum Therapeutics (NASDAQ:CTNM) - Pioneering Differentiated Therapies for Neuro-Inflammation and Immunology Indications
Published on March 12, 2025
Contineum Therapeutics (CTNM): Pioneering Innovative Therapies for Unmet Needs in Neuroscience, Inflammation, and Immunology
Published on November 27, 2024